Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 2, 2013, Pages 166-179

  Gulnaz, Asma ^a   Sayyed, Ali H ^a   Amin, Farah ^a   Khan, Abrar Ul Haq ^b   Aslam, Muhammad A ^a   Shaikh, Rehan S ^a   Ali, Muhammad ^a  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b UNIVERSITY OF AGRICULTURE   (Pakistan)

Author keywords

Hepatitis B virus; Hepatitis C virus; Liver cancer; Polymorphism; XPD; XRCC1; XRCC3

Indexed keywords

PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; X RAY CROSS COMPLEMENTING GROUP 1; X RAY CROSS COMPLEMENTING GROUP 3;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAKISTAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ANTHROPOMETRY; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHILD; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SEX FACTORS; SMOKING; XERODERMA PIGMENTOSUM GROUP D PROTEIN; YOUNG ADULT;

EID: 84872058133     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328359a775     Document Type: Article

References (52)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clin 2011; 61:69-90
2. Bhurgri Y. Karachi Cancer Registry Data - implications for the national cancer control program of Pakistan. Asian Pac J Cancer Prev 2004; 5:77-82
3. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: A systematic review. Br J Cancer 2007; 96:1127-1134 (Pubitemid 46608308)
4. Yusuf MA, Badar F, Meerza F, Khokhar RA, Ali FA, Sarwar S, et al. Survival from hepatocellular caircinoma at a cancer hospital in Pakistan. Asian Pac J Cancer Prev 2007; 8:272-274
5. Tong CYW, Khan R, Beeching NJ, Tariq WUZ, Hart CA, Ahmad N, et al. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma. Epidemiol Infect 1996; 117:327-332 (Pubitemid 26345242)
6. Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: An overview. Asian Pac J Cancer Prev 2004; 5:118-125
7. Lopez LJ, Marrero JA. Hepatocellular carcinoma. Curr Opin Gastroenterol 2004; 20:248-253 (Pubitemid 38526775)
8. Akinyinka OO, Falade AG, Ogunbiyi O, Johnson AOK. Hepatocellular carcinoma in Nigerian children. Ann Trop Paediatr 2001; 21: 165-168 (Pubitemid 32655059)
9. Stern MC, Umbach DM, Lunn RM, Taylor JA. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11:939-943 (Pubitemid 35014902)
10. Sugimura T, Terada M, Yokota J, Horohashi S, Wakabayashi K. Multiple genetic alterations in human carcinogenesis. Environ Health Perspect 1992; 98:5-12 (Pubitemid 23061777)
11. Rahman SZ, Nouraldeen AM, Ahmed AE. Molecular interaction of 2,3-[14C]-Acrylonitrile with DNA in gastric tissues of rat. J Biochem Toxicol 1994; 9:121-128
12. Miller MC, Mohrenweiser HW, Bell DA. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 2001; 120:269-280 (Pubitemid 32375093)
13. Duarte MC, Colombo J, Arbr Silva AE. Polymorphism of the DNA repair genes XRCC1 and XRCC3 in a Brazilian population. Gen Mol Biol 2005; 28:397-401 (Pubitemid 43078712)
14. Lindahl T, Wood RD. Quality control by DNA repair. Science 1999; 286:1897-1905 (Pubitemid 129515891)
15. Shen M, Hung RJ, Brennan P, Malavielle C, Donato F, Placidi D, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposure, and bladder cancer risk in a case-control study in Northern Italy. Cancer Epidemiol Biomarkers Prev 2003; 12:1234-1240 (Pubitemid 37499450)
16. Shen MR, Jones LM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998; 58:604-608 (Pubitemid 28099464)
17. Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 2005; 89:15-21 (Pubitemid 40228443)
18. Brenneman MA, Weiss AE, Nickoloff JA, Chen DJ. XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat Res 2000; 459:89-97 (Pubitemid 30139457)
19. Dianov GL, Sleeth KM, Dianova II, Allinson SL. Repair of abasic sites in DNA. Mut Res 2003; 531:157-163 (Pubitemid 37456729)
20. Long XD, Ma Y, Zhou YF, Yao JG, Ban FZ, Huang YZ, et al. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer 2009; 9:400
21. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 2002; 17:463-469 (Pubitemid 35414774)
22. Kertat K, Rosdahl I, Sun XF, Synnerstad I, Zhang H. The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: A case control study in the Swedish population. Oncol Rep 2008; 20:179-183
23. Spitz MR,Wu X,Wang Y,Wang LE, Shete S, Amos CI, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61:1354-1357 (Pubitemid 34292555)
24. Huang JY, Ye F, Chen HZ, Lu WG, Xie X. Amino acid substitution polymorphisms of the DNA repair gene MGMT and the susceptibility to cervical carcinoma. Carcinogenesis 2007; 28:1314-1322 (Pubitemid 47062692)
25. Andreassi MG, Foffa I, Manfredi S, Botto N, Cioppa A, Picano E. Genetic polymorphisms in XRCC1, OGG1, APE1 and XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal DNA damage in interventional cardiologists. Mutat Res 2009; 666:57-63
26. Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen MH, et al. XPD/ ERCC2 polymorphisms and risk of head and neck cancer: A case-control analysis. Carcinogenesis 2000; 21:2219-2223 (Pubitemid 32049228)
27. Yang ZH, Du B, Wei YS, Zhang JH, Zhou B, Liang WB, et al. Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma. DNA Cell Biol 2007; 26:491-496 (Pubitemid 47105611)
28. Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CKJ, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2001; 10:217-222 (Pubitemid 34288532)
29. Lockett KL, Snowhite IV, Hu JJ. Nucleotide-excision repair and prostate cancer risk. Cancer Lett 2005; 220:125-135 (Pubitemid 40568769)
30. Porter TR, Richards FM, Houlston RS, Evans DGR, Jankowski JA, Macdonald F, et al. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 2002; 21:1928-1933 (Pubitemid 34259196)
31. Abdel-Rahman SZ, Soliman AS, Bondy ML, Omar S, El-Badawy SA, Khaled HM, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 2000; 159:79-86
32. Spitz MR, McPherson RS, Jiang H, Hsu TC, Trizna Z, Lee JJ, et al. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev 1997; 6:687-692 (Pubitemid 27427623)
33. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: Effects on aflatoxin B-1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999; 59:2557-2561 (Pubitemid 29269097)
34. Ramachandran S, Ramadas K, Hariharan R, Kumar RR, Pillai MR. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 2006; 42:350-362
35. Han JL, Hankinson SE, Zhang SMM, De Vivo I, Hunter DJ. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13:520-524 (Pubitemid 38737885)
36. Kiran M, Saxena R, Chawla YK, Kaur J. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem 2009; 327:7-13
37. Lee JM, Lee YC, Yang SY, Yang PW, Luh SP, Lee CJ, et al. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 2001; 95:240-246
38. Ezzat S, Abdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, El-Ghorory L, et al. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health 2005; 208:329-339 (Pubitemid 41207425)
39. Boffetta P, Nyberg F. Contribution of environmental factors to cancer risk. Br Med Bull 2003; 68:71-94 (Pubitemid 38258221)
40. McGlynn KA, Abnet CC, Zhang M, Sun XD, Fan JH, O'Brien TR, et al. Serum concentrations of 1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) and 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and risk of primary liver cancer. J Natl Cancer Inst 2006; 98:1005-1010 (Pubitemid 44288165)
41. Geng J, Zhang Q, Zhu CD, Wang JH, Chen LB. XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: A meta-Analysis. Urology 2009; 74:648-653
42. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-Analysis. Lung Cancer 2006; 54:267-283 (Pubitemid 44634141)
43. Geng Y, Yu QY, Sicinska E, Das M, Schneider JE, Bhattacharya S, et al. Cyclin E ablation in the mouse. Cell 2003; 114:431-443 (Pubitemid 37100992)
44. Wang B, Wang D, Huang G, Zhang C, Xu DH, Zhou WP. XRCC1 polymorphisms and risk of colorectal cancer: A meta-Analysis. Int J Colorectal Dis 2010; 25:313-321
45. Wang ZH, Xu BH, Lin DX, Tan W, Leaw S, Hong XN, et al. XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. Lung Cancer 2008; 62:99-104
46. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-Analysis of the literatures. Breast Cancer Res Treat 2009; 115:137-144
47. Long XD, Ma Y, Qu DY, Liu YG, Huang ZQ, Huang YZ, et al. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China. Ann Epidemiol 2008; 18: 572-578 (Pubitemid 351802260)
48. Ryk C, Kumar R, Sanyal S, de Verdier PJB, Hemminki K, Larsson P, et al. Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Lett 2006; 241:142-149
49. Sun HM, Qiao YD, Zhang XL, Xu LD, Jia XY, Sun DL, et al. XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: A metaanalysis. Cancer Sci 2010; 101:1777-1782
50. Zhao L, Long XD, Yao J-G, Wang C, Mad Y, Huang Y-Z, et al. Genetic polymorphism of XRCC3 codon 241 and Helicobacter pylori infectionrelated gastric antrum adenocarcinoma in Guangxi Population, China: A hospital-based case-control study. Cancer Epidemiol 2011; 35:564-568
51. FeaverWJ, Svejstrup JQ, Bardwell L, Bardwell AJ, Buratowski S, Gulyas KD, et al. Dual roles of a multiprotein complex from Saccharomyces cerevisiae in transcription and DNA-repair. Cell 1993; 75:1379-1387 (Pubitemid 24021912)
52. Dybdahl M, Vogel U, Frentz G, Wallin H, Nexo BA. Polymorphisms in the DNA repair gene XPD: Correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 1999; 8:77-81 (Pubitemid 29090873)